Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study-Reference-Cited by-同舟云学术

Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study

Published:2016-05-26 Issue:1 Volume:105 Page:26-34
ISSN:0028-3835
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Berdelou Amandine,Boige Valérie,Arfi-Rouche Julia,Malka David,Ederhy Stéphane,Izzedine Hassan,Leboulleux Sophie,Chougnet Cécile N.,Burtin Pascal,De Baere Thierry,Laplanche Agnès,Elias Dominique,Schlumberger Martin,Scoazec Jean-Yves,Ducreux Michel,Baudin Eric

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours;Journal of Neuroendocrinology;2023-10-25

2. A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours;Therapeutic Advances in Medical Oncology;2023-01

3. Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study;Advances in Therapy;2022-04-13

4. Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience;Cancers;2021-10-26

5. Oxaliplatin and 5-fluorouracil (FOLFOX) in advanced well differentiated digestive neuroendocrine tumors: a multicenter national retrospective study from the French Group of Endocrine Tumors (GTE);Neuroendocrinology;2021-07-26